Friedreich's Ataxia clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • CTI-1601 in Subjects With Friedreich's Ataxia

    open to eligible people ages 2-60

    An open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of CTI-1601 enrolling adolescent and adult patients with FRDA who have participated in a prior clinical study of CTI-1601 as well as children (age 2 years and older), adolescents and adults with FRDA who have not participated in a prior clinical study of CTI-1601.

    San Francisco, California and other locations

Last updated: